The co‐chaperone p23 promotes prostate cancer motility and metastasis

Prostate cancer is an androgen receptor (AR)‐dependent malignancy at initiation and progression, therefore hormone therapy is the primary line of systemic treatment. Despite initial disease regression, tumours inevitably recur and progress to an advanced castration‐resistant state a major feature of...

Descripción completa

Detalles Bibliográficos
Autores principales: Querol Cano, Laia, Lavery, Derek N., Sin, Soraya, Spanjaard, Emma, Brooke, Greg N., Tilman, Jessica D., Abroaf, Ahmed, Gaughan, Luke, Robson, Craig N., Heer, Rakesh, Mauri, Francesco, de Rooij, Johan, Driouch, Keltouma, Bevan, Charlotte L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510206/
https://www.ncbi.nlm.nih.gov/pubmed/25241147
http://dx.doi.org/10.1016/j.molonc.2014.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510206/
https://www.ncbi.nlm.nih.gov/pubmed/25241147
http://dx.doi.org/10.1016/j.molonc.2014.08.014

Ejemplares similares